Pfizer, Janssen, and Burrill are among the pharmas represented at BioNJ’s big interactive event for companies involved in diagnostics and personalized medicine on March 14, 2012 at Princeton University. The BioNJ Diagnostics & Personalized Medicine Innovation Summit and Funding Roundtable, a half-day summit meeting, will feature
G. Steven Burrill Chief Executive Officer, Burrill & Company
Joseph P. Hammang, Ph.D. Senior Director, Worldwide Science Policy, Pfizer Inc.
Paul Kildal-Brandt Global Alliance Leader, Janssen Diagnostics, News alert: apparently Janssen just bought Belgium-based Virco.
Aydogan Ozcan, Ph.D. The Scientist’s Top Innovation Award Winner of 2011 Associate Professor, UCLA Electrical Engineering & Bioengineering Department
Register for $95 if you are not a member of BioNJ. The Carl A. Fields Center is cheek-by-jowl with the engineering complex, on the corner of Prospect and Olden Avenues.
Princeton Comment 